Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

The antioxidant N-acetylcysteine protects from lung emphysema but induces lung adenocarcinoma in mice.

Breau M, Houssaini A, Lipskaia L, Abid S, Born E, Marcos E, Czibik G, Attwe A, Beaulieu D, Palazzo A, Flaman JM, Bourachot B, Collin G, Tran Van Nhieu J, Bernard D, Mechta-Grigoriou F, Adnot S.

JCI Insight. 2019 Oct 3;4(19). pii: 127647. doi: 10.1172/jci.insight.127647.

2.

Myocardial ischemia during ventilator weaning: a prospective multicenter cohort study.

Bedet A, Tomberli F, Prat G, Bailly P, Kouatchet A, Mortaza S, Vivier E, Rosselli S, Lipskaia L, Carteaux G, Razazi K, Mekontso Dessap A.

Crit Care. 2019 Sep 18;23(1):321. doi: 10.1186/s13054-019-2601-8.

3.

CCR2/CCR5-mediated macrophage-smooth muscle cell crosstalk in pulmonary hypertension.

Abid S, Marcos E, Parpaleix A, Amsellem V, Breau M, Houssaini A, Vienney N, Lefevre M, Derumeaux G, Evans S, Hubeau C, Delcroix M, Quarck R, Adnot S, Lipskaia L.

Eur Respir J. 2019 Oct 10;54(4). pii: 1802308. doi: 10.1183/13993003.02308-2018. Print 2019 Oct.

PMID:
31320454
4.

Causes and consequences of cardiac fibrosis in patients referred for surgical aortic valve replacement.

Galat A, Guellich A, Bodez D, Lipskaia L, Moutereau S, Bergoend E, Hüe S, Ternacle J, Mohty D, Monin JL, Derumeaux G, Radu C, Damy T.

ESC Heart Fail. 2019 Aug;6(4):649-657. doi: 10.1002/ehf2.12451. Epub 2019 May 21.

5.

The STATus of STAT3 in Lung Cell Senescence?

Adnot S, Lipskaia L, Bernard D.

Am J Respir Cell Mol Biol. 2019 Jul;61(1):5-6. doi: 10.1165/rcmb.2019-0013ED. No abstract available.

6.

Cardiac adenylyl cyclase overexpression precipitates and aggravates age-related myocardial dysfunction.

Mougenot N, Mika D, Czibik G, Marcos E, Abid S, Houssaini A, Vallin B, Guellich A, Mehel H, Sawaki D, Vandecasteele G, Fischmeister R, Hajjar RJ, Dubois-Randé JL, Limon I, Adnot S, Derumeaux G, Lipskaia L.

Cardiovasc Res. 2019 Oct 1;115(12):1778-1790. doi: 10.1093/cvr/cvy306.

PMID:
30605506
7.

Anthracycline cardiotoxicity: looking for new therapeutic approaches targeting cell senescence?

Abid S, Lipskaia L, Adnot S.

Cardiovasc Res. 2018 Aug 1;114(10):1304-1305. doi: 10.1093/cvr/cvy108. No abstract available.

PMID:
29718137
8.

New Nitric Oxide Donor NCX 1443: Therapeutic Effects on Pulmonary Hypertension in the SAD Mouse Model of Sickle Cell Disease.

Abid S, Kebe K, Houssaïni A, Tomberli F, Marcos E, Bizard E, Breau M, Parpaleix A, Tissot CM, Maitre B, Lipskaia L, Derumeaux G, Bastia E, Mekontso-Dessap A, Adnot S.

J Cardiovasc Pharmacol. 2018 May;71(5):283-292. doi: 10.1097/FJC.0000000000000570.

PMID:
29438213
9.

mTOR pathway activation drives lung cell senescence and emphysema.

Houssaini A, Breau M, Kebe K, Abid S, Marcos E, Lipskaia L, Rideau D, Parpaleix A, Huang J, Amsellem V, Vienney N, Validire P, Maitre B, Attwe A, Lukas C, Vindrieux D, Boczkowski J, Derumeaux G, Pende M, Bernard D, Meiners S, Adnot S.

JCI Insight. 2018 Feb 8;3(3). pii: 93203. doi: 10.1172/jci.insight.93203. eCollection 2018 Feb 8.

10.

Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.

Amsellem V, Abid S, Poupel L, Parpaleix A, Rodero M, Gary-Bobo G, Latiri M, Dubois-Rande JL, Lipskaia L, Combadiere C, Adnot S.

Am J Respir Cell Mol Biol. 2017 May;56(5):597-608. doi: 10.1165/rcmb.2016-0201OC.

PMID:
28125278
11.

Osteopontin, a Key Mediator Expressed by Senescent Pulmonary Vascular Cells in Pulmonary Hypertension.

Saker M, Lipskaia L, Marcos E, Abid S, Parpaleix A, Houssaini A, Validire P, Girard P, Noureddine H, Boyer L, Vienney N, Amsellem V, Marguerit L, Maitre B, Derumeaux G, Dubois-Rande JL, Jourdan-Lesaux C, Delcroix M, Quarck R, Adnot S.

Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1879-90. doi: 10.1161/ATVBAHA.116.307839. Epub 2016 Jul 21.

PMID:
27444202
12.

Selective Tuberous Sclerosis Complex 1 Gene Deletion in Smooth Muscle Activates Mammalian Target of Rapamycin Signaling and Induces Pulmonary Hypertension.

Houssaini A, Abid S, Derumeaux G, Wan F, Parpaleix A, Rideau D, Marcos E, Kebe K, Czibik G, Sawaki D, Treins C, Dubois-Randé JL, Li Z, Amsellem V, Lipskaia L, Pende M, Adnot S.

Am J Respir Cell Mol Biol. 2016 Sep;55(3):352-67. doi: 10.1165/rcmb.2015-0339OC.

PMID:
26991739
13.

Extracellular Calpain/Calpastatin Balance Is Involved in the Progression of Pulmonary Hypertension.

Wan F, Letavernier E, Abid S, Houssaini A, Czibik G, Marcos E, Rideau D, Parpaleix A, Lipskaia L, Amsellem V, Gellen B, Sawaki D, Derumeaux G, Dubois-Randé JL, Delcroix M, Quarck R, Baud L, Adnot S.

Am J Respir Cell Mol Biol. 2016 Sep;55(3):337-51. doi: 10.1165/rcmb.2015-0257OC.

PMID:
26974350
14.

Axial stretch-dependent cation entry in dystrophic cardiomyopathy: Involvement of several TRPs channels.

Aguettaz E, Lopez JJ, Krzesiak A, Lipskaia L, Adnot S, Hajjar RJ, Cognard C, Constantin B, Sebille S.

Cell Calcium. 2016 Apr;59(4):145-155. doi: 10.1016/j.ceca.2016.01.001. Epub 2016 Jan 6.

15.

Dominant negative Ras attenuates pathological ventricular remodeling in pressure overload cardiac hypertrophy.

Ramos-Kuri M, Rapti K, Mehel H, Zhang S, Dhandapany PS, Liang L, García-Carrancá A, Bobe R, Fischmeister R, Adnot S, Lebeche D, Hajjar RJ, Lipskaia L, Chemaly ER.

Biochim Biophys Acta. 2015 Nov;1853(11 Pt A):2870-84. doi: 10.1016/j.bbamcr.2015.08.006. Epub 2015 Aug 8. Erratum in: Biochim Biophys Acta. 2016 Apr;1863(4):785.

16.

Telomere Dysfunction and Cell Senescence in Chronic Lung Diseases: Therapeutic Potential.

Adnot S, Amsellem V, Boyer L, Marcos E, Saker M, Houssaini A, Kebe K, Dagouassat M, Lipskaia L, Boczkowski J.

Pharmacol Ther. 2015 Sep;153:125-34. doi: 10.1016/j.pharmthera.2015.06.007. Epub 2015 Jun 18. Review.

PMID:
26096607
17.

Role for telomerase in pulmonary hypertension.

Mouraret N, Houssaïni A, Abid S, Quarck R, Marcos E, Parpaleix A, Gary-Bobo G, Dubois-Randé JL, Derumeaux G, Boczkowski J, Delcroix M, Blasco MA, Lipskaia L, Amsellem V, Adnot S.

Circulation. 2015 Feb 24;131(8):742-755. doi: 10.1161/CIRCULATIONAHA.114.013258. Epub 2014 Dec 30.

18.

Expression of sarco (endo) plasmic reticulum calcium ATPase (SERCA) system in normal mouse cardiovascular tissues, heart failure and atherosclerosis.

Lipskaia L, Keuylian Z, Blirando K, Mougenot N, Jacquet A, Rouxel C, Sghairi H, Elaib Z, Blaise R, Adnot S, Hajjar RJ, Chemaly ER, Limon I, Bobe R.

Biochim Biophys Acta. 2014 Nov;1843(11):2705-18. doi: 10.1016/j.bbamcr.2014.08.002. Epub 2014 Aug 7.

19.

CCR5 as a treatment target in pulmonary arterial hypertension.

Amsellem V, Lipskaia L, Abid S, Poupel L, Houssaini A, Quarck R, Marcos E, Mouraret N, Parpaleix A, Bobe R, Gary-Bobo G, Saker M, Dubois-Randé JL, Gladwin MT, Norris KA, Delcroix M, Combadière C, Adnot S.

Circulation. 2014 Sep 9;130(11):880-891. doi: 10.1161/CIRCULATIONAHA.114.010757. Epub 2014 Jul 3.

20.

Synergistic role of protein phosphatase inhibitor 1 and sarco/endoplasmic reticulum Ca2+ -ATPase in the acquisition of the contractile phenotype of arterial smooth muscle cells.

Lipskaia L, Bobe R, Chen J, Turnbull IC, Lopez JJ, Merlet E, Jeong D, Karakikes I, Ross AS, Liang L, Mougenot N, Atassi F, Lompré AM, Tarzami ST, Kovacic JC, Kranias E, Hajjar RJ, Hadri L.

Circulation. 2014 Feb 18;129(7):773-85. doi: 10.1161/CIRCULATIONAHA.113.002565. Epub 2013 Nov 18.

21.

Benefit of SERCA2a gene transfer to vascular endothelial and smooth muscle cells: a new aspect in therapy of cardiovascular diseases.

Lipskaia L, Hadri L, Lopez JJ, Hajjar RJ, Bobe R.

Curr Vasc Pharmacol. 2013 Jul;11(4):465-79. Review.

22.

Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy.

Lompré AM, Hadri L, Merlet E, Keuylian Z, Mougenot N, Karakikes I, Chen J, Atassi F, Marchand A, Blaise R, Limon I, McPhee SW, Samulski RJ, Hajjar RJ, Lipskaia L.

Gene Ther. 2013 Sep;20(9):901-12. doi: 10.1038/gt.2013.13. Epub 2013 Mar 28.

23.

Molecular targets of current and prospective heart failure therapies.

Chemaly ER, Hajjar RJ, Lipskaia L.

Heart. 2013 Jul;99(14):992-1003. doi: 10.1136/heartjnl-2012-302970. Epub 2013 Jan 24. Review.

PMID:
23349349
24.

SERCA2a gene transfer prevents intimal proliferation in an organ culture of human internal mammary artery.

Lipskaia L, Hadri L, Le Prince P, Esposito B, Atassi F, Liang L, Glorian M, Limon I, Lompre AM, Lehoux S, Hajjar RJ.

Gene Ther. 2013 Apr;20(4):396-406. doi: 10.1038/gt.2012.50. Epub 2012 Jul 5.

25.

The Notch pathway attenuates interleukin 1β (IL1β)-mediated induction of adenylyl cyclase 8 (AC8) expression during vascular smooth muscle cell (VSMC) trans-differentiation.

Keuylian Z, de Baaij JH, Gueguen M, Glorian M, Rouxel C, Merlet E, Lipskaia L, Blaise R, Mateo V, Limon I.

J Biol Chem. 2012 Jul 20;287(30):24978-89. doi: 10.1074/jbc.M111.292516. Epub 2012 May 21. Erratum in: J Biol Chem. 2013 Jan 11;288(2):1278. Gueguen, Marie [added].

26.

Molecular targets in heart failure gene therapy: current controversies and translational perspectives.

Kairouz V, Lipskaia L, Hajjar RJ, Chemaly ER.

Ann N Y Acad Sci. 2012 Apr;1254:42-50. doi: 10.1111/j.1749-6632.2012.06520.x. Review.

27.

A calcium-sensitive promoter construct for gene therapy.

Merlet E, Lipskaia L, Marchand A, Hadri L, Mougenot N, Atassi F, Liang L, Hatem SN, Hajjar RJ, Lompré AM.

Gene Ther. 2013 Mar;20(3):248-54. doi: 10.1038/gt.2012.30. Epub 2012 Mar 29.

28.

SERCA2a controls the mode of agonist-induced intracellular Ca2+ signal, transcription factor NFAT and proliferation in human vascular smooth muscle cells.

Bobe R, Hadri L, Lopez JJ, Sassi Y, Atassi F, Karakikes I, Liang L, Limon I, Lompré AM, Hatem SN, Hajjar RJ, Lipskaia L.

J Mol Cell Cardiol. 2011 Apr;50(4):621-33. doi: 10.1016/j.yjmcc.2010.12.016. Epub 2010 Dec 29.

29.

Implication of adenylyl cyclase 8 in pathological smooth muscle cell migration occurring in rat and human vascular remodelling.

Gueguen M, Keuylian Z, Mateo V, Mougenot N, Lompré AM, Michel JB, Meilhac O, Lipskaia L, Limon I.

J Pathol. 2010 Jul;221(3):331-42. doi: 10.1002/path.2716.

PMID:
20527026
30.

SERCA2a gene transfer enhances eNOS expression and activity in endothelial cells.

Hadri L, Bobe R, Kawase Y, Ladage D, Ishikawa K, Atassi F, Lebeche D, Kranias EG, Leopold JA, Lompré AM, Lipskaia L, Hajjar RJ.

Mol Ther. 2010 Jul;18(7):1284-92. doi: 10.1038/mt.2010.77. Epub 2010 May 11.

31.

Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure.

Lipskaia L, Chemaly ER, Hadri L, Lompre AM, Hajjar RJ.

Expert Opin Biol Ther. 2010 Jan;10(1):29-41. doi: 10.1517/14712590903321462. Review.

32.

Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation.

Sassi Y, Lipskaia L, Vandecasteele G, Nikolaev VO, Hatem SN, Cohen Aubart F, Russel FG, Mougenot N, Vrignaud C, Lechat P, Lompré AM, Hulot JS.

J Clin Invest. 2008 Aug;118(8):2747-57. doi: 10.1172/JCI35067.

33.

Role of sarco/endoplasmic reticulum calcium content and calcium ATPase activity in the control of cell growth and proliferation.

Lipskaia L, Hulot JS, Lompré AM.

Pflugers Arch. 2009 Jan;457(3):673-85. doi: 10.1007/s00424-007-0428-7. Epub 2008 Jan 11. Review.

PMID:
18188588
34.

Treatment of heart failure by calcium cycling gene therapy.

Lipskaia L, Ly H, Kawase Y, Hajjar RJ, Lompre AM.

Future Cardiol. 2007 Jul;3(4):413-23. doi: 10.2217/14796678.3.4.413.

PMID:
19804232
35.

Mutation of delta-sarcoglycan is associated with Ca(2+) -dependent vascular remodeling in the Syrian hamster.

Lipskaia L, Pinet C, Fromes Y, Hatem S, Cantaloube I, Coulombe A, Lompré AM.

Am J Pathol. 2007 Jul;171(1):162-71.

36.
37.

Sarco/endoplasmic reticulum Ca2+-ATPase gene transfer reduces vascular smooth muscle cell proliferation and neointima formation in the rat.

Lipskaia L, del Monte F, Capiod T, Yacoubi S, Hadri L, Hours M, Hajjar RJ, Lompré AM.

Circ Res. 2005 Sep 2;97(5):488-95. Epub 2005 Aug 4.

PMID:
16081870
38.

Alteration in temporal kinetics of Ca2+ signaling and control of growth and proliferation.

Lipskaia L, Lompré AM.

Biol Cell. 2004 Feb;96(1):55-68. Review.

PMID:
15093128
39.

Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8).

Georget M, Mateo P, Vandecasteele G, Lipskaia L, Defer N, Hanoune J, Hoerter J, Lugnier C, Fischmeister R.

FASEB J. 2003 Aug;17(11):1380-91.

PMID:
12890691
40.

Phosphatidylinositol 3-kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation.

Lipskaia L, Pourci ML, Deloménie C, Combettes L, Goudounèche D, Paul JL, Capiod T, Lompré AM.

Circ Res. 2003 May 30;92(10):1115-22. Epub 2003 May 1.

PMID:
12730091
41.

Augmentation of cardiac contractility with no change in L-type Ca2+ current in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8).

Georget M, Mateo P, Vandecasteele G, Jurevicius J, Lipskaia L, Defer N, Hanoune J, Hoerter J, Fischmeister R.

FASEB J. 2002 Oct;16(12):1636-8. Epub 2002 Aug 21.

PMID:
12206999
42.

Enhanced cardiac function in transgenic mice expressing a Ca(2+)-stimulated adenylyl cyclase.

Lipskaia L, Defer N, Esposito G, Hajar I, Garel MC, Rockman HA, Hanoune J.

Circ Res. 2000 Apr 14;86(7):795-801.

PMID:
10764414
43.

Resistance to adriamycin in human chronic promyeloleukemia line K562 correlates with directed genome destabilization--amplification of MDR1 gene and nonrandom changes in karyotype structure.

Grinchuk TM, Pavlenko MA, Lipskaia LA, Sorokina EA, Tarunina MV, Berezkina EV, Kovaleva ZV, Ignatova TN.

Tsitologiia. 1998;40(7):652-60. Russian.

PMID:
9793179
44.

Adenylyl cyclase activity and gene expression during mesodermal differentiation of the P19 embryonal carcinoma cells.

Lipskaia L, Grépin C, Defer N, Hanoune J.

J Cell Physiol. 1998 Jul;176(1):50-6.

PMID:
9618144
45.

Different expression of adenylyl cyclase isoforms after retinoic acid induction of P19 teratocarcinoma cells.

Lipskaia L, Djiane A, Defer N, Hanoune J.

FEBS Lett. 1997 Oct 6;415(3):275-80.

46.

[The karyotypic variability of Chinese hamster CHLV-79 RJK cells characterized by multiple drug resistance resulting from the amplification of the mdr gene family].

Grinchuk TM, Lipskaia LA, Artsybasheva IV, Sorokina EA, Pan'shina IuT, Ignatova TN.

Tsitologiia. 1996;38(2):161-72. Russian.

PMID:
8754132
47.

[Amplification of genes from the mdr family in rodent cells resistant to ethidium bromide].

Lipskaia LA, Efimova EV, Grinchuk TM, Nekrasova TN, Artsybasheva IV, Kovaleva ZV, Berezkina EV, Vasiukhin VI, Ignatova TN.

Dokl Akad Nauk. 1994 Oct;338(4):541-4. Russian. No abstract available.

PMID:
7820085
48.

[The isolation and genetic characteristics of the new cell line of mouse myeloma spEBR-5 selected for ethidium bromide resistance and characterized by multiple drug resistance].

Berezkina EV, Lipskaia LA, Grinchuk TM, Kovaleva ZV, Sorokina EA, Vasiukhin VI, Ignatova TN.

Tsitologiia. 1994;36(7):687-95. Russian.

PMID:
7900209
50.

[The amplification and overexpression of mdr-family genes in ethidium bromide-resistant Chinese hamster CHO-K1 cells and in the hybrids of sensitive and resistant cells].

Lipskaia LA, Grinchuk TM, Efimova EV, Artsybasheva IV, Sorokina EA, Vasiukhin VI, Ignatova TN.

Tsitologiia. 1994;36(12):1236-44. Russian.

PMID:
7544510

Supplemental Content

Loading ...
Support Center